Tissue factor methods and compositions for coagulation and tumor treatment
Abstract
The invention comprises a astounding discovery, namely the tissue factor (TF) component and fully formed by generalized same specific place of the vessel is vascularizing tumour. Therefore, the invention claims a washbasin can be used for with a specific hemoglutination and method and composition for treating tumour, wherein the composition comprises a hemoglutination defect tissue factor. The invention's TF device and method can be with improved TF clamp are independent of period of the steering, or with the medicament, common to chemotherapeutic agent and targeted immunotoxin and targeted the hemoglutination ligand with, and/or (F VII a) or the F VII a 0.02-0.05% for with factor VII a.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
36 members in 18 offices
Priority claims16
| Document | Office | Kind | Date |
|---|---|---|---|
| 3592097 | United States of America | P | |
| 3592097 | United States of America | P | |
| 3620597 | United States of America | P | |
| 3620597 | United States of America | P | |
| 4242797 | United States of America | P | |
| 4242797 | United States of America | P | |
| 9801012 | United States of America | W | |
| 9801012 | United States of America | W | |
| 35920P | – | – | – |
| 36205P | – | – | – |
| 42427P | – | – | – |
| 9801012 | – | – | – |
| US19970035920P | – | – | – |
| US19970036205P | – | – | – |
| US19970042427P | – | – | – |
| WO1998US01012 | – | – | – |
Members36
| Document | Office | Kind | |
|---|---|---|---|
| CA2278106A1 | Canada | A1 | |
| WO9831394A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU5924398A | Australia | A | |
| WO9831394A3 | World Intellectual Property Organization (WIPO) | A3 | |
| NO993567D0 | Norway | D0 | |
| NO993567L | Norway | L | |
| EP0988056A2 | European Patent Office (EPO) | A2 | |
| CN1251532A | China | A | |
| BR9806793A | Brazil | A | |
| HU0001376A2 | Hungary | A2 | |
| HUP0001376A2 | Hungary | A2 | |
| US6132729A | United States of America | A | |
| US6132730A | United States of America | A | |
| KR20000070389A | Republic of Korea | A | |
| US6156321A | United States of America | A | |
| IL130908D0 | Israel | D0 | |
| NZ336720A | New Zealand | A | |
| AU735187B2 | Australia | B2 | |
| AU735187C | Australia | C | |
| JP2002514201A | Japan | A | |
| EP0988056B1 | European Patent Office (EPO) | B1 | |
| AT244579TThis record | Austria | T | |
| ATE244579T1 | Austria | T1 | |
| DE69816297D1 | Germany | D1 | |
| PT988056E | Portugal | E | |
| US2003232753A1 | United States of America | A1 | |
| DE69816297T2 | Germany | T2 | |
| ES2197458T3 | Spain | T3 | |
| DE69816297T9 | Germany | T9 | |
| CY2416B1 | Cyprus | B1 | |
| CA2278106C | Canada | C | |
| KR100565883B1 | Republic of Korea | B1 | |
| US7101557B2 | United States of America | B2 | |
| NO323702B1 | Norway | B1 | |
| CN100333796C | China | C | |
| US7951356B1 | United States of America | B1 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Ceased due to non-payment of the annual feeCeasedREN | REN | |
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Publication, DOCDB
- 244579
- Publication, EPODOC
- AT244579T
- Application
- 98902634
- Application, DOCDB
- 98902634
- Application, EPODOC
- AT19980902634T
Titles2
- German
- VERFAHREN UND ZUSAMMENSETZUNGEN DES GEWEBEFAKTORS ZUR KOAGULATION UND BEHANDLUNG VON TUMOREN
- English
- METHOD AND COMPOSITIONS OF THE FABRIC FACTOR FOR COAGULATION AND TREATMENT OF TUMORS
Classification
- CPC, 9
- A61K47/6813
- A61K39/395
- A61K47/6435
- Y10S530/829
- Y10S530/827
- A61P7/02
- A61P7/04
- A61P35/00
- Y10S514/834
- IPC, 5
- A61K45 00
- A61K38 00
- A61K47 48
- A61P7 02
- A61P35 00